Literature DB >> 15287908

Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.

Jun Yao1, Suzana S Petanceska, Thomas J Montine, David M Holtzman, Stephen D Schmidt, Carolyn A Parker, Michael J Callahan, William J Lipinski, Charles L Bisgaier, Brian A Turner, Ralph A Nixon, Ralph N Martins, Charles Ouimet, Jonathan D Smith, Peter Davies, Eugene Laska, Michelle E Ehrlich, Lary C Walker, Paul M Mathews, Sam Gandy.   

Abstract

Aging and apolipoprotein E (APOE) isoform are among the most consistent risks for the development of Alzheimer's disease (AD). Metabolic factors that modulate risk have been elusive, though oxidative reactions and their by-products have been implicated in human AD and in transgenic mice with overt histological amyloidosis. We investigated the relationship between the levels of endogenous murine amyloid beta (Abeta) peptides and the levels of a marker of oxidation in mice that never develop histological amyloidosis [i.e. APOE knockout (KO) mice with or without transgenic human APOEepsilon3 or human APOEepsilon4 alleles]. Aging-, gender-, and APOE-genotype-dependent changes were observed for endogenous mouse brain Abeta40 and Abeta42 peptides. Levels of the oxidized lipid F2-isoprostane (F2-isoPs) in the brains of the same animals as those used for the Abeta analyses revealed aging- and gender-dependent changes in APOE KO and in human APOEepsilon4 transgenic KO mice. Human APOEepsilon3 transgenic KO mice did not exhibit aging- or gender-dependent increases in F2-isoPs. In general, the changes in the levels of brain F2-isoPs in mice according to age, gender, and APOE genotype mirrored the changes in brain Abeta levels, which, in turn, paralleled known trends in the risk for human AD. These data indicate that there exists an aging-dependent, APOE-genotype-sensitive rise in murine brain Abeta levels despite the apparent inability of the peptide to form histologically detectable amyloid. Human APOEepsilon3, but not human APOEepsilon4, can apparently prevent the aging-dependent rise in murine brain Abeta levels, consistent with the relative risk for AD associated with these genotypes. The fidelity of the brain Abeta/F2-isoP relationship across multiple relevant variables supports the hypothesis that oxidized lipids play a role in AD pathogenesis, as has been suggested by recent evidence that F2-isoPs can stimulate Abeta generation and aggregation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287908     DOI: 10.1111/j.1471-4159.2004.02532.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease.

Authors:  A-Ryeong Gwon; Jong-Sung Park; Thiruma V Arumugam; Yong-Kook Kwon; Sic L Chan; Seol-Hee Kim; Sang-Ha Baik; Sunghee Yang; Young-Kwang Yun; Yuri Choi; Saerom Kim; Sung-Chun Tang; Dong-Hoon Hyun; Aiwu Cheng; Charles E Dann; Michel Bernier; Jaewon Lee; William R Markesbery; Mark P Mattson; Dong-Gyu Jo
Journal:  Aging Cell       Date:  2012-04-09       Impact factor: 9.304

Review 2.  The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease.

Authors:  Sam Gandy
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

3.  Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model.

Authors:  Saravanan S Karuppagounder; Hui Xu; Qingli Shi; Lian H Chen; Steve Pedrini; David Pechman; Harriet Baker; M Flint Beal; Sam E Gandy; Gary E Gibson
Journal:  Neurobiol Aging       Date:  2008-04-10       Impact factor: 4.673

Review 4.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 5.  Cognitive Changes with Reproductive Aging, Perimenopause, and Menopause.

Authors:  Kelly N Morgan; Carol A Derby; Carey E Gleason
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

6.  Sex-dependent actions of amyloid beta peptides on hippocampal choline carriers of postnatal rats.

Authors:  Z Kristofiková; J Rícný; I Kozmiková; D Rípová; P Zach; J Klaschka
Journal:  Neurochem Res       Date:  2006-03       Impact factor: 3.996

7.  Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice.

Authors:  Sean S Davies; Chris Bodine; Elena Matafonova; Brooke G Pantazides; Nathalie Bernoud-Hubac; Fiona E Harrison; Sandra J Olson; Thomas J Montine; Venkataraman Amarnath; L Jackson Roberts
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

8.  Effects of human apolipoprotein E isoforms on the amyloid beta-protein concentration and lipid composition in brain low-density membrane domains.

Authors:  Maho Morishima-Kawashima; Xianlin Han; Yu Tanimura; Hiroki Hamanaka; Mariko Kobayashi; Takashi Sakurai; Minesuke Yokoyama; Koji Wada; Nobuyuki Nukina; Shinobu C Fujita; Yasuo Ihara
Journal:  J Neurochem       Date:  2007-05       Impact factor: 5.372

Review 9.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

Review 10.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.